SCHEMBL2056293

SCHEMBL2056293

Cc1nc2ccc(Cl)cc2o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 1/20 0.61
▸ PSMB8 P28062 1/20 0.56
▸ PSMB5 P28074 1/20 0.56
▸ S1PR3 Q99500 2/20 0.49
▸ ALDH1A1 P00352 4/20 0.47
▸ POLB P06746 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ SNCA P37840 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ FBP1 P09467 2/20 0.44
▸ SOS1 Q07889 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353166 0.84 LMNA (0.61) PSMB8ALDH1A1POLBSMN1; SMN2MAPT
SCHEMBL31507497 0.84 LMNA (0.61) PSMB8ALDH1A1POLBSMN1; SMN2MAPT
SCHEMBL14330030 0.79 GAA (0.59) ALDH1A1POLBSMN1; SMN2MAPTRAB9A
SCHEMBL5541680 0.79 KDM4E (0.63) ALDH1A1POLBSMN1; SMN2MAPTRAB9A
SCHEMBL895172 0.79 PIK3CG (0.66) PIK3CGPSMB8PSMB5S1PR3ALDH1A1
SCHEMBL24030082 0.79 PIK3CG (0.41) PIK3CGPSMB8PSMB5S1PR3POLB
SCHEMBL9252792 0.76 PIK3CG (0.61) PIK3CGPSMB8PSMB5S1PR3ALDH1A1
SCHEMBL3062851 0.76 PIK3CG (0.61) PIK3CGPSMB8PSMB5S1PR3ALDH1A1
SCHEMBL19086925 0.76 PIK3CG (0.61) PIK3CGPSMB8PSMB5S1PR3ALDH1A1
SCHEMBL13177964 0.76 ALDH1A1 (0.47) ALDH1A1POLBSMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116751137-B Method for preparing chloro aromatic compound by photo-induced nitroarene denitration chlorination 华中师范大学 2025-03-07 — — CN disclosed
US-20230321091-A1 SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES EDGEWISE THERAPEUTICS, INC. 2023-10-12 — — US disclosed
CN-116751137-A Method for preparing chloro aromatic compound by photo-induced nitroarene denitration chlorination 华中师范大学 2023-09-15 — — CN disclosed
US-11242354-B2 4-sulfur substituted podophyllotoxin derivative and preparation method therefor and use thereof Tang, YaJie 2022-02-08 — — US disclosed
WO-2021231615-A1 SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES EDGEWISE THERAPEUTICS, INC. (US) 2021-11-18 — — WO disclosed
US-11066537-B2 Composition, film, infrared cut filter, solid image pickup element, infrared sensor, camera module, and novel compound FUJIFILM CORPORATION (JP) 2021-07-20 — — US disclosed
EP-3438095-B1 PYRIDAZINONE COMPOUND OR ITS SALT, AND HERBICIDE CONTAINING IT ISHIHARA SANGYO KAISHA (JP) 2021-06-16 — — EP disclosed
US-10870638-B2 Pyridazinone compound or its salt, and herbicide containing it ISHIHARA SANGYO KAISHA, LTD. (JP) 2020-12-22 — — US disclosed
US-20200390100-A1 SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES BAYER AG (DE) 2020-12-17 — — US disclosed
US-20200345700-A1 LSD1 INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF MEDSHINE DISCOVERY INC. (CN) 2020-11-05 — — US disclosed
US-20080119478-A1 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis OTSUKA PHAMACEUTICAL CO., LTD. (JP) 2008-05-22 — — US disclosed
US-20080119478-A1 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis OTSUKA PHAMACEUTICAL CO., LTD. (JP) 2008-05-22 — — US disclosed
US-7338651-B2 Multi-use multimodal imaging chelates TEXAS TECH UNIVERSITY SYSTEM (US) 2008-03-04 — — US disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 — — US disclosed
WO-2007034251-A1 AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIGANDS SANOFI-AVENTIS (FR) 2007-03-29 — — WO disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 — — US disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 — — EP disclosed
US-4600797-A NITRATING AN AMINOBENZENE WHICH HAS A PROTECTEDD AMINO GROUP BAYER AKTIENGESELLSCHAFT (DE) 1986-07-15 — — US disclosed
EP-0049711-B1 PROCESS FOR THE PRODUCTION OF NITRO-AMINO-BENZENES BAYER AG (DE) 1984-02-29 — — EP disclosed
EP-0049711-A1 Process for the production of nitro-amino-benzenes BAYER AG (DE) 1982-04-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200390100-A1 SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES DDT, NOTUM, AGPS PIK3CG 3924/4885PSMB8 4144/4885PSMB5 2125/4885
US-20230321091-A1 SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES IL6, MUSK, SMN1; SMN2 PIK3CG 2078/4885PSMB8 1693/4885PSMB5 990/4885
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 PIK3CG 4480/4885PSMB8 2916/4885PSMB5 2976/4885
US-20080119478-A1 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis NR2C2, NR0B2, NR4A2 PIK3CG 4032/4885PSMB8 2818/4885PSMB5 1739/4885
US-10870638-B2 Pyridazinone compound or its salt, and herbicide containing it H1-0, H1-4, H1-3 PIK3CG 2511/4885PSMB8 4453/4885PSMB5 2662/4885
US-20200345700-A1 LSD1 INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF KDM1B, KDM1A, KDM2A PIK3CG 4744/4885PSMB8 2976/4885PSMB5 2376/4885
US-11242354-B2 4-sulfur substituted podophyllotoxin derivative and preparation method therefor and use thereof WEE1, WEE2, DHFR PIK3CG 3615/4885PSMB8 2272/4885PSMB5 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback